NFKB1 and Miyoshi myopathy: For example, increased IL-17 in the bone marrow microenvironment can promote the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), which in turn enhances disease activity in particular bone marrow cancers, such as multiple myeloma (MM) [34].